1989
DOI: 10.1016/0360-3016(89)90899-7
|View full text |Cite
|
Sign up to set email alerts
|

Structure-activity relationships for benzotriazine DI-N-oxides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
29
0

Year Published

1990
1990
2014
2014

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 66 publications
(31 citation statements)
references
References 18 publications
2
29
0
Order By: Relevance
“…A novel class that exhibits selective toxicity toward hypoxic cells is the 1,2,4-benzotriazine 1,4-dioxides [45][46][47], an iminium type. Tirapazamine (3-amino-1,2,4-benzotriazine 1,4-dioxide, 4), the lead member, exhibits superior selectivity to that of many other hypoxic cytotoxins, such as, mitomycin C and misonidazole, and is currently undergoing phase II and III clinical trials for treatment of various cancers [48].…”
Section: B Tirapazaminementioning
confidence: 99%
“…A novel class that exhibits selective toxicity toward hypoxic cells is the 1,2,4-benzotriazine 1,4-dioxides [45][46][47], an iminium type. Tirapazamine (3-amino-1,2,4-benzotriazine 1,4-dioxide, 4), the lead member, exhibits superior selectivity to that of many other hypoxic cytotoxins, such as, mitomycin C and misonidazole, and is currently undergoing phase II and III clinical trials for treatment of various cancers [48].…”
Section: B Tirapazaminementioning
confidence: 99%
“…Hypoxic cell fractions, believed to be present in mammalian solid tumours, are thought to be the reason for the unsuccessful ability to cure some human malignancies by radiotherapy (Moulder & Rockwell, 1987). The benzotriazine di-N-oxide, amino-1,2,4-benzotriazine-1,4-dioxide) is the lead compound of a new series of hypoxic cell cytotoxins currently being investigated as anticancer drugs (Zeman et al, 1989). It is up to 150 times more effective at preventing colony formation if the tumour cells were treated with SR 4233 under hypoxic conditions than under aerobic conditions in vitro (Zeman et al, 1986) suggesting that it may be useful in radiation therapy.…”
mentioning
confidence: 99%
“…The drugs investigated were the bioreductive quinone antibiotic mitomycin C (Kennedy et al, 1980); a monofunctional alkylating 2-nitroimidazole RSU-1069 (Adams et al, 1984;Stratford et al, 1986); and the benzotriazine-di-N-oxide SR4233 (Zeman et al, 1986(Zeman et al, , 1989.…”
mentioning
confidence: 99%